Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05236413 · ClinicalTrials.gov registry record · NA

The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF

A NA study of Heart Failure With Preserved Ejection Fraction, sponsored by University of Virginia.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT05236413: Recruiting NA study of Heart Failure With Preserved Ejection Fraction, sponsored by University of Virginia.

NCT05236413 is a NA study of Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 36 participants, below the 2,287-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05236413, a NA study of Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by University of Virginia.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

This study is trying to find out how best to improve common measures of health and survival in those diagnosed with heart failure with preserved ejection fraction (HFpEF) through the implementation of 4 weeks of an exercise training program consisting of high intensity interval training, dietary approaches to stop hypertension (DASH diet), or a combination of the two. Currently there are not established guidelines that have been shown to improve clinical end points in those with this HFpEF.

Conditions Studied

Heart Failure With Preserved Ejection Fraction

Interventions

  • BEHAVIORAL High Intensity Interval Exercise
  • BEHAVIORAL Dietary Approaches to Stop Hypertension (DASH) Diet
  • BEHAVIORAL Exercise + DASH Diet

Study Locations (1)

Virginia

  • University of Virginia University Hospital - Charlottesville

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2022-04-01
Est. Completion 2025-08-01
Phase NA
University of Virginia

449 total trials

What NCT05236413 shows while recruiting

NCT05236413 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 2,287-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 3 interventions - of which High Intensity Interval Exercise is the first listed.

NCT05236413 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT05236413 about?

NCT05236413 is a clinical study titled "The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF". This study is trying to find out how best to improve common measures of health and survival in those diagnosed with heart failure with preserved ejection fraction (HFpEF) through the implementation of 4 weeks of an exercise training program consisting of high intensity interval training, dietary app...

What is the current status of trial NCT05236413?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2022-04-01. Estimated completion is 2025-08-01.

What conditions does trial NCT05236413 study?

This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction.

What interventions are being tested in trial NCT05236413?

The interventions under investigation include: High Intensity Interval Exercise (BEHAVIORAL), Dietary Approaches to Stop Hypertension (DASH) Diet (BEHAVIORAL), Exercise + DASH Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT05236413?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05236413 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure With Preserved Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05236413's enrollment target sits among peer trials

36 29th of 42 higher than 14 of 42 other Heart Failure With Preserved Ejection Fraction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure With Preserved Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05236413

Source: ClinicalTrials.gov NCT05236413, the US trial registry maintained by the National Library of Medicine. NCT05236413 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.